MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkac287

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2022

HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.

Breton Guillaume, Diallo Oumou Hawa, Cissé Mohamed, Diallo Oumou Hawa, Diallo Néné Aissatou, Soumaoro Sény Agnès, Camara Yalikhatou, Montoyo Alice, Rouzioux Christine, Koita Youssouf, Peytavin Gilles, Tubiana Roland, Frange Pierre, ANRS 12344-DIAVINA study group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Nearly half of HIV-infected children worldwide are born in West and Central African countries where access to prevention of mother-to-child transmission of HIV (PMTCT) programmes is still limited. WHO recommends reinforced antiretroviral prophylaxis for infants at high risk of mother-to-child transmission of HIV (MTCT) but its implementation needs further investigation in the field.

METHODS

The prospective ANRS 12344-DIAVINA study evaluated the feasibility of a strategy combining early infant diagnosis (EID) and reinforced antiretroviral prophylaxis in high-risk infants as identified by interviews with mothers at Ignace Deen Hospital, Conakry, Guinea.

RESULTS

6493 women were admitted for delivery, 6141 (94.6%) accepted HIV testing and 114 (1.9%) were HIV positive. Among these, 51 high-risk women and their 56 infants were included. At birth, a blood sample was collected for infant EID and reinforced antiretroviral prophylaxis was initiated in 48/56 infants (86%, 95% CI 77%-95%). Iron supplementation was given to 35% of infants for non-severe anaemia. Retrospective measurement of maternal plasma viral load (pVL) at delivery revealed that 52% of women had pVL < 400 copies/mL attributable to undisclosed HIV status and/or antiretroviral intake. Undisclosed HIV status was associated with self-stigmatization (85% versus 44%, P = 0.02). Based on the results of maternal pVL at delivery, 'real' high-risk infants were more frequently lost to follow-up (44% versus 8%, P < 0.01) in comparison with low-risk infants, and this was associated with mothers' stigmatization (69% versus 31%, P < 0.01).

CONCLUSIONS

Reinforced antiretroviral prophylaxis and EID at birth are widely feasible. However, mothers' self-disclosure of HIV status and antiretroviral intake do not allow adequate evaluation of MTCT risk, which argues for maternal pVL measurement near delivery. Furthermore, actions against stigmatization are crucial to improve PMTCT.

Для цитирования: Breton Guillaume, Diallo Oumou Hawa, Cissé Mohamed, Diallo Oumou Hawa, Diallo Néné Aissatou, Soumaoro Sény Agnès, Camara Yalikhatou, Montoyo Alice, Rouzioux Christine, Koita Youssouf, Peytavin Gilles, Tubiana Roland, Frange Pierre, ANRS 12344-DIAVINA study group. HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.. The Journal of antimicrobial chemotherapy. 2022. DOI: 10.1093/jac/dkac287.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.